Pharma companies are spending billions on a treatment based off old drugs, with little evidence it will extend lives.

WASHINGTON — The U.S. Food and Drug Administration said on Monday it would remove the strictest "black box" warnings from ...

The fate of the enhanced Affordable Care Act premium tax credits — initially bolstered during the pandemic — is still unclear ...

Commissioner Marty Makary said the agency is asking drugmakers to remove the strict black box warnings, with the goal of encouraging more women to take them. Labels on the medicines currently list ...

After a leading study caused the FDA to slap its most stringent warning on hormone replacement therapies for menopause more ...

Since Jeffrey Hessekiel took the legal reins of Exelixis in 2014, revenue has ballooned from $25 million to $2.2 billion.

Trump administration drug deals link U.S. prices to global lows, aiming to cut costs via Pfizer, AstraZeneca, and TrumpRx in 2026.

The U.S. Department of Health and Human Services announced that the U.S. Food and Drug Administration is initiating the removal of broad “black ...

The U.S. FDA moves to remove black box warnings from hormone replacement therapy products used for menopause. Read more here.

Pfizer Inc. acquires Metsera, Inc., beating Novo Nordisk, for up to $86.25/share. Click for my analysis of the deal and what ...

BridgeBio said Pfizer’s filing of a complaint with the NAD “is an attempt to bypass the FDA, the federal agency responsible for overseeing prescription drug advertising, and to challenge promotional ...